In agreement with previous studies, our initial observations in six NSCLC cell lines have shown that Enz inhibits cell growth and activation of PKC, p-42/44, AKT, and GSK3 β (Faul et al, 2003; Graff et al, 2005). Here, PRRT2 is linked to non-small cell lung carcinoma.